Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/1999
07/20/1999US5925733 DNA polymerase of gamma herpes viruses associated with Kaposi's sarcoma and retroperitoneal fibromatosis
07/20/1999US5925731 Endothelin antagonist peptides
07/20/1999US5925729 Isolated amino acid sequence encoding antigen; use as agent for treating the cancer for which the antigen is a ?marker?, as well as in various diagnostic approaches to oncology
07/20/1999US5925568 It is also useful to be able to harvest haematopoietic cells prior to chemotherapy or radiotherapy, thus protecting them from the effects of this therapy; after therapy, the cells can be returned to the patient.
07/20/1999US5925566 Signal transduction polypeptide with two zinc finger domains; binds to epidermal growth factor receptor and released after activation to localize in nucleolus; anticarcinogenic agents; angiogenesis inhibitors
07/20/1999US5925564 Expression vector systems and method of use
07/20/1999US5925559 Phagemids and process of preparation
07/20/1999US5925558 Assays for protein kinases using fluorescent protein substrates
07/20/1999US5925555 Propagating virus with reverse transcriptase activity in brain cells
07/20/1999US5925553 Ternary complex of zinc, catalytic site of enzyme, and heterocyclic inhibitory compound; antiarthritic agents
07/20/1999US5925549 Soluble 7-transmembrane domain G-protein-coupled receptor compositions and methods
07/20/1999US5925548 Disclosed are various dna, protein and cellular compositions and methods of making and using such constitutively active receptors.
07/20/1999US5925547 Nucleic acid encoding novel protein domain which binds tyrosine phosphorylated proteins
07/20/1999US5925546 Immunologically active polypeptides with altered toxicity useful for the preparation of an antipertussis vaccine
07/20/1999US5925542 Nucleic acid encoding human phosphodiesterase regulatory subunit
07/20/1999US5925540 Synthetic antifreeze peptide and synthetic gene coding for its production
07/20/1999US5925539 Human pelota homolog
07/20/1999US5925536 Receptor-type phosphotyrosine phosphatase-β
07/20/1999US5925533 Tropinin I calibrator and method of use thereof in a sandwich immunoassay
07/20/1999US5925529 The inventive detection system involves the use of a ?tethered? ligand for probing receptor binding.
07/20/1999US5925528 Murine cell lines which over produce acidic fibroblast growth factor (aFGF) and method of using same
07/20/1999US5925526 Paraneoplastic cerebellar degeneration (pcd) is a disorder of the cerebellum found in association with neoplasms usually of lung, ovary, breast, or hodgkins disease.
07/20/1999US5925522 Salmonella nucleotide sequences, methods of detection of salmonella nucleotide sequences, and method of detection of salmonella
07/20/1999US5925516 Medicaments for the treatment of papillomavirus diseases
07/20/1999US5925513 Diagnosis and treatment of AIDS onset
07/20/1999US5925512 Monoclonal antibody which specifically binds to mutant hepatitis b virus surface antigen ?a? determinant
07/20/1999US5925362 Method to elicit an antitumor response with human prostate-specific antigen
07/20/1999US5925360 Isolated dna sequence encoding protein of hog cholera virus or antigenic fragment comprising specified amino acid sequence
07/20/1999US5925358 Insertion of dna into fowlpox virus genome
07/20/1999US5925352 Administering antiinflammatory amount of anti-neutrophil chemotactic factor antibodies
07/20/1999US5925351 Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
07/20/1999US5925347 Viral vector vaccines comprising nucleic acids encoding eimeria proteins for poultry vaccination against coccidiosis
07/20/1999US5925343 Canine granulocyte macrophage colony stimulating factor
07/20/1999US5925333 Screening for compounds that alter the binding by scavengers
07/20/1999US5925331 Technetium-99m labeled peptides for thrombus imaging
07/20/1999CA2155001C Htlv-i and htlv-ii gp21 derived peptides for use in diagnostics
07/20/1999CA2146367C Calcium channel blocking polypeptides from heteropoda venatoria
07/20/1999CA2082394C Pseudomonas exotoxins of low animal toxicity and high cytocidal activity
07/20/1999CA2069043C Quantitation of samples utilizing capillary electrophoresis
07/20/1999CA2053921C Synthetic peptides for an hiv-1 vaccine
07/20/1999CA1340661C Respriatory synctial virus: vaccines and diagnostic assays
07/20/1999CA1340656C Membrane anchor/active compound conjugate, its preparation and its use
07/15/1999WO1999035292A1 Compositions and methods for treating cells having double minute dna
07/15/1999WO1999035291A1 Isothermal transcription based amplification assay for the detection and quantitation of macrophage derived chemokine rna
07/15/1999WO1999035279A1 G protein-related kinase mutants in essential hypertension
07/15/1999WO1999035273A1 The process for expression and production of recombinant protein gp90 derived from glicoprotein envelop of equine infectious anemia virus eiav
07/15/1999WO1999035272A1 RECOMBINANT P37/FlaA AS A DIAGNOSTIC REAGENT
07/15/1999WO1999035270A1 Streptococcal heat shock proteins of the hsp60 family
07/15/1999WO1999035269A2 Method for controlling the division and/or elongation of eukariotic cells
07/15/1999WO1999035268A1 IL-1 delta DNA AND POLYPEPTIDES
07/15/1999WO1999035267A1 Human and murine il-17d, cytokine related to interleukin-17: dna and polypeptides
07/15/1999WO1999035266A2 Human urotensin ii
07/15/1999WO1999035265A1 Human vps35/mem3-related protein
07/15/1999WO1999035264A1 H14 dna and polypeptides
07/15/1999WO1999035263A2 Il-17rh dna and polypeptides
07/15/1999WO1999035262A2 Apoptosis inducing molecule ii
07/15/1999WO1999035260A1 Non-identical genes and their application in improved molec ular adjuvants
07/15/1999WO1999035259A1 Identification of lysolipid receptors involved in inflammatory response
07/15/1999WO1999035258A1 Nucleic acid markers for apospory-specific genomic region
07/15/1999WO1999035253A1 Secreted proteins and polynucleotides encoding them
07/15/1999WO1999035252A2 Secreted proteins and polynucleotides encoding them
07/15/1999WO1999035246A1 Novel steroid-activated nuclear receptors and uses therefor
07/15/1999WO1999035241A1 Transgenic rabbit that expresses a functional human lipoprotein (a)
07/15/1999WO1999035170A2 Compositions and methods for the treatment of tumor
07/15/1999WO1999035169A2 Methods and compositions for treating and diagnosing insulin related disorders
07/15/1999WO1999035168A1 Secreted proteins and polynucleotides encoding them
07/15/1999WO1999035167A1 Peptide epitopes recognised by antifilaggrin autoantibodies in serum from rheumatoid arthritis patients
07/15/1999WO1999035166A1 Compounds and methods for modulating occludin related tissue permeability
07/15/1999WO1999035165A1 Secreted proteins and polynucleotides encoding them
07/15/1999WO1999035160A1 Human fk506 binding proteins
07/15/1999WO1999035159A1 Lymphoma/leukemia oncogene, oncoprotein and methods of use
07/15/1999WO1999035158A1 36 human secreted proteins
07/15/1999WO1999035106A2 Mammalian edg-7 receptor homologs
07/15/1999WO1999034836A1 Methods of controlling cell differentiation and growth using a fusion protein and a drug
07/15/1999WO1999034826A1 Methods and compositions for desensitisation
07/15/1999WO1999034825A1 Fertility impairing vaccine and method of use
07/15/1999WO1999034822A1 Formulations for amylin agonist peptides
07/15/1999WO1999034819A2 Use of citrulline peptides derived from filaggrin for treating autoimmune diseases
07/15/1999WO1999034818A1 Broad spectrum chemokine antagonist and uses thereof
07/15/1999WO1999034816A1 Method for administering monomeric insulin analogs
07/15/1999WO1999034815A1 Method for administering aspb28-human insulin
07/15/1999WO1999034814A1 Interferon responsive transcript
07/15/1999WO1999034670A1 Gene mutant animals
07/15/1999WO1999029729A3 Antagonists of neuropilin receptor function and use thereof
07/15/1999WO1999028466A8 Compositions and methods of use of het
07/15/1999WO1999025857A3 Transgenic models of inflammatory disease
07/15/1999WO1999025837A3 Method for producing virus-like particles on the basis of polyoma viruses
07/15/1999WO1999025823A3 Recombinant allergen with reduced enzymatic activity
07/15/1999WO1999025734A3 Th2 CELL DEPLETION; COMPOSITIONS; METHODS
07/15/1999WO1999024573A3 SOYBEAN HOMOLOG OF SEED-SPECIFIC TRANSCRIPTION ACTIVATOR FROM $i(PHASEOLUS VULGARIS)
07/15/1999WO1999024466A3 Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes
07/15/1999WO1999023867A3 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use
07/15/1999WO1999021992A9 Nucleic acid molecules encoding a glutamate receptor
07/15/1999WO1999018990A9 The il-1 receptor related protein 3 (il-1rrp3)
07/15/1999WO1999018216A9 Chimeric vaccine against tick-borne encephalitis virus
07/15/1999WO1999016298A9 Nepovirus resistance in grapevine
07/15/1999WO1999013095A9 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
07/15/1999WO1998053066A9 Smad2 phosphorylation and interaction with smad4
07/15/1999DE19801154A1 Preparation of pure recombinant thyroid stimulating hormone receptor useful for detection of autoantibodies in human serum
07/15/1999DE19800363A1 New inhibitors of serine protease useful for treating inflammation